Sign up to save your podcasts
Or
Share Short Shorts for 2nd Week of May, 2022
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Short Shorts for 2nd Week of May, 2022
Vidcast: https://youtu.be/VqIN3664keY
Short Shorts are quickie reports about cutting edge medical and healthcare discoveries. They’re worth knowing about this 2nd week of May, 2022.
Silkworms help to repair Achille’s tendons. From UCLA and the Terasaki Institute for Medical Innovation comes the novel combination of silk from the Bombyx mori silkworm and a water-retaining gel called GelMA. These materials form a matrix in which mesenchymal stem cells can grow to produce a strong, biocompatible material called SG that can repair tendons. This material works in rats and soon will be tested in humans.
https://onlinelibrary.wiley.com/doi/10.1002/smll.202107714
A new portable MRI device offers on-the-spot evaluations of wrist and elbow joint integrity for athletes such as tennis and baseball players at high risk for overuse injuries. Developed at Japan’s University of Tsukuba, the car-mounted device can be deployed in the field at the practice sites to catch cartilage and bony injuries early while still reversible with physical therapy and activity restriction.
https://www.jstage.jst.go.jp/article/mrms/advpub/0/advpub_tn.2021-0158/_article
A new wearable sensor that interfaces with the body’s fluids using a microneedle patch is announced by UC-San Diego. The patch’s microneedles have different enzymes on their tips capable of reacting with glucose, alcohol, and lactic acid as they poke just below the skin’s surface into the bloodless interstitial fluid. The disposable patch sends information to a reusable electronic module that transmits it to a computer or possibly your phone for processing and alerting you about elevated sugar, alcohol, or exercise metabolite levels.
https://www.nature.com/articles/s41551-022-00887-1
An experimental drug in the Eli Lilly & Co. pipeline delivers exceptional weight loss for obese and overweight persons that is on par with surgical approaches. Named Tirzepatide and delivered by a once-weekly injection, the drug is compounded from two hormones GLP-1 and GIP, known as incretins, that both share in regulating sugar metabolism. GLP-1 is already found in the FDA-approved drug semaglutide, branded as Ozempic and Rybelsus, and the addition of GIP seems to drive more impressive weight loss.
https://www.sciencealert.com/experimental-drug-breaks-record-for-weight-loss-in-latest-clinical-trial-results
There you have the latest health reveals for the 2nd week of May, 2022. When additional information about these developments becomes available, I’ll pass it on to you.
#tendon #achilles #silkworm #silk #stemcells #wrist #elbow #mri #tennis #baseball #wearables #glucose #alcohol #lactate #microneedles #tirzepatide #weightloss #obesity #bariatricsurgery #incretins
View all episodes
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/VqIN3664keY
Short Shorts are quickie reports about cutting edge medical and healthcare discoveries. They’re worth knowing about this 2nd week of May, 2022.
Silkworms help to repair Achille’s tendons. From UCLA and the Terasaki Institute for Medical Innovation comes the novel combination of silk from the Bombyx mori silkworm and a water-retaining gel called GelMA. These materials form a matrix in which mesenchymal stem cells can grow to produce a strong, biocompatible material called SG that can repair tendons. This material works in rats and soon will be tested in humans.
https://onlinelibrary.wiley.com/doi/10.1002/smll.202107714
A new portable MRI device offers on-the-spot evaluations of wrist and elbow joint integrity for athletes such as tennis and baseball players at high risk for overuse injuries. Developed at Japan’s University of Tsukuba, the car-mounted device can be deployed in the field at the practice sites to catch cartilage and bony injuries early while still reversible with physical therapy and activity restriction.
https://www.jstage.jst.go.jp/article/mrms/advpub/0/advpub_tn.2021-0158/_article
A new wearable sensor that interfaces with the body’s fluids using a microneedle patch is announced by UC-San Diego. The patch’s microneedles have different enzymes on their tips capable of reacting with glucose, alcohol, and lactic acid as they poke just below the skin’s surface into the bloodless interstitial fluid. The disposable patch sends information to a reusable electronic module that transmits it to a computer or possibly your phone for processing and alerting you about elevated sugar, alcohol, or exercise metabolite levels.
https://www.nature.com/articles/s41551-022-00887-1
An experimental drug in the Eli Lilly & Co. pipeline delivers exceptional weight loss for obese and overweight persons that is on par with surgical approaches. Named Tirzepatide and delivered by a once-weekly injection, the drug is compounded from two hormones GLP-1 and GIP, known as incretins, that both share in regulating sugar metabolism. GLP-1 is already found in the FDA-approved drug semaglutide, branded as Ozempic and Rybelsus, and the addition of GIP seems to drive more impressive weight loss.
https://www.sciencealert.com/experimental-drug-breaks-record-for-weight-loss-in-latest-clinical-trial-results
There you have the latest health reveals for the 2nd week of May, 2022. When additional information about these developments becomes available, I’ll pass it on to you.
#tendon #achilles #silkworm #silk #stemcells #wrist #elbow #mri #tennis #baseball #wearables #glucose #alcohol #lactate #microneedles #tirzepatide #weightloss #obesity #bariatricsurgery #incretins